Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Virginia Borges

Concepts (585)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
141
2026
2246
12.570
 Why?
Pregnancy Complications, Neoplastic
14
2021
57
2.950
 Why?
Postpartum Period
19
2024
345
2.710
 Why?
Cancer Survivors
18
2024
281
2.260
 Why?
Receptors, Estrogen
21
2025
412
2.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
21
2025
1791
1.990
 Why?
Antineoplastic Agents, Hormonal
14
2025
170
1.940
 Why?
Carcinoma, Ductal, Breast
10
2023
81
1.750
 Why?
Mastectomy
17
2024
152
1.680
 Why?
Protein Kinase Inhibitors
7
2025
918
1.480
 Why?
Lactation
9
2021
190
1.260
 Why?
Brain Neoplasms
11
2025
1282
1.250
 Why?
Female
159
2026
75814
1.150
 Why?
Carcinoma, Intraductal, Noninfiltrating
7
2023
60
1.130
 Why?
Neoplasm Metastasis
13
2025
674
1.080
 Why?
Breast
10
2021
155
1.030
 Why?
Triple Negative Breast Neoplasms
7
2025
201
0.980
 Why?
Oxazoles
8
2025
46
0.960
 Why?
Adult
95
2025
39319
0.950
 Why?
Antineoplastic Agents
12
2023
2162
0.940
 Why?
Trastuzumab
13
2023
98
0.930
 Why?
Receptors, Progesterone
7
2025
337
0.920
 Why?
Pyridines
9
2025
560
0.890
 Why?
Pregnancy
34
2025
7035
0.870
 Why?
Quinazolines
8
2025
260
0.860
 Why?
Humans
168
2026
141284
0.850
 Why?
Mammary Glands, Human
7
2020
66
0.850
 Why?
Supreme Court Decisions
1
2022
11
0.760
 Why?
Mammary Glands, Animal
9
2021
127
0.710
 Why?
BRCA2 Protein
5
2024
62
0.690
 Why?
Carcinoma
3
2021
230
0.690
 Why?
Semaphorins
4
2025
35
0.670
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
37
0.670
 Why?
Fertility Preservation
7
2025
53
0.660
 Why?
Drug Resistance, Neoplasm
3
2022
840
0.630
 Why?
Maternal Age
1
2020
128
0.620
 Why?
Breast Feeding
6
2025
441
0.620
 Why?
Antigens, CD
6
2025
537
0.610
 Why?
Neoadjuvant Therapy
6
2021
429
0.610
 Why?
Middle Aged
57
2025
34658
0.600
 Why?
Estradiol
5
2019
523
0.580
 Why?
Prospective Studies
32
2025
7805
0.570
 Why?
Extracellular Vesicles
1
2020
153
0.570
 Why?
Prognosis
15
2022
4080
0.550
 Why?
Carcinoma in Situ
3
2022
44
0.550
 Why?
Parity
7
2022
110
0.540
 Why?
Young Adult
37
2024
13727
0.540
 Why?
Neoplasm Recurrence, Local
13
2023
1075
0.530
 Why?
Lymphatic Metastasis
10
2021
327
0.520
 Why?
Neoplasm Staging
17
2022
1397
0.510
 Why?
Neoplasms, Second Primary
3
2024
98
0.510
 Why?
Chemotherapy, Adjuvant
14
2025
383
0.500
 Why?
Quality of Life
11
2024
3024
0.490
 Why?
Cyclooxygenase 2
5
2020
172
0.470
 Why?
Mutation
11
2025
4006
0.440
 Why?
Capecitabine
5
2023
42
0.430
 Why?
Aromatase Inhibitors
6
2019
58
0.430
 Why?
Liver Neoplasms
4
2016
741
0.430
 Why?
Carcinoma, Lobular
2
2012
54
0.420
 Why?
Melanoma
4
2018
786
0.420
 Why?
Skin Neoplasms
4
2013
851
0.420
 Why?
Mastectomy, Segmental
6
2022
101
0.420
 Why?
Combined Modality Therapy
10
2023
1243
0.410
 Why?
Puerperal Disorders
2
2014
34
0.400
 Why?
BRCA1 Protein
4
2024
78
0.390
 Why?
Stromal Cells
3
2013
117
0.370
 Why?
Tumor Suppressor Protein p53
2
2021
528
0.360
 Why?
Biomarkers, Tumor
10
2023
1250
0.360
 Why?
Anxiety
7
2022
1078
0.350
 Why?
Sexual Partners
3
2022
188
0.340
 Why?
Nevus, Pigmented
1
2011
34
0.340
 Why?
Epithelial Cells
6
2018
1105
0.340
 Why?
Neoplasm Invasiveness
6
2020
510
0.330
 Why?
Disease-Free Survival
7
2023
713
0.330
 Why?
Fertility
5
2025
165
0.320
 Why?
Tamoxifen
7
2021
203
0.320
 Why?
Cyclophosphamide
5
2020
257
0.310
 Why?
Estrogens
4
2015
371
0.310
 Why?
Radiosurgery
3
2021
389
0.300
 Why?
Antibodies, Monoclonal, Humanized
7
2025
908
0.300
 Why?
Adjuvants, Immunologic
2
2022
238
0.300
 Why?
Aged
29
2025
24836
0.300
 Why?
Gene Expression Profiling
8
2020
1761
0.300
 Why?
Risk Factors
17
2024
10490
0.300
 Why?
Thrombophilia
1
2009
90
0.290
 Why?
GPI-Linked Proteins
4
2025
78
0.290
 Why?
T-Lymphocytes
6
2018
1996
0.290
 Why?
Incidence
7
2024
2809
0.290
 Why?
Quinolines
3
2025
169
0.280
 Why?
Mice
21
2025
17969
0.280
 Why?
Cell Line, Tumor
10
2025
3502
0.280
 Why?
Animals
31
2025
37328
0.280
 Why?
Doxorubicin
5
2020
369
0.280
 Why?
Breast Neoplasms, Male
2
2018
29
0.270
 Why?
Neoplasms
6
2022
2731
0.270
 Why?
Employment
2
2019
180
0.270
 Why?
Gene Expression Regulation, Neoplastic
4
2021
1439
0.270
 Why?
Kaplan-Meier Estimate
4
2020
910
0.270
 Why?
Cohort Studies
11
2024
5809
0.260
 Why?
Decision Making
4
2022
949
0.260
 Why?
Premenopause
5
2025
120
0.260
 Why?
Maytansine
2
2018
18
0.250
 Why?
Myeloid-Derived Suppressor Cells
2
2018
72
0.250
 Why?
Estrogen Receptor alpha
3
2025
145
0.250
 Why?
Adaptation, Psychological
2
2022
680
0.240
 Why?
Time Factors
7
2020
6951
0.240
 Why?
Disease Management
3
2021
634
0.240
 Why?
Estrogen Receptor Antagonists
1
2025
3
0.240
 Why?
Reproductive History
2
2015
12
0.230
 Why?
Ovarian Reserve
1
2025
16
0.230
 Why?
Hematopoietic Stem Cell Transplantation
1
2011
670
0.230
 Why?
CD8-Positive T-Lymphocytes
5
2023
911
0.230
 Why?
Primary Ovarian Insufficiency
1
2025
40
0.230
 Why?
Macrophages
4
2018
1478
0.230
 Why?
Dimethyl Sulfoxide
1
2005
40
0.220
 Why?
Cell Plasticity
1
2025
37
0.220
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2022
100
0.220
 Why?
Proportional Hazards Models
2
2022
1268
0.220
 Why?
Genetic Predisposition to Disease
6
2024
2366
0.220
 Why?
Transforming Growth Factor beta1
1
2025
169
0.210
 Why?
Spectrometry, Mass, Electrospray Ionization
1
2005
178
0.210
 Why?
Adolescent
20
2024
22116
0.210
 Why?
Bupropion
1
2004
45
0.210
 Why?
Follow-Up Studies
5
2025
5222
0.210
 Why?
Disease Progression
10
2020
2808
0.210
 Why?
Reproductive Techniques, Assisted
1
2024
41
0.210
 Why?
Lymph Nodes
3
2019
494
0.210
 Why?
Drug Administration Schedule
3
2018
771
0.200
 Why?
Diarrhea
3
2019
183
0.200
 Why?
Immunotherapy
3
2025
641
0.200
 Why?
Liver
3
2020
1821
0.200
 Why?
Disease Models, Animal
5
2020
4414
0.200
 Why?
Pharmaceutical Preparations
1
2005
169
0.190
 Why?
Cell Proliferation
5
2021
2502
0.190
 Why?
Multiple Sclerosis
1
2008
468
0.190
 Why?
Age Factors
9
2021
3295
0.190
 Why?
Hypertension, Pregnancy-Induced
1
2023
69
0.190
 Why?
Aurora Kinase A
2
2019
56
0.190
 Why?
Women's Health
1
2024
308
0.190
 Why?
Treatment Outcome
9
2025
11216
0.190
 Why?
Chromatography, Liquid
1
2004
452
0.180
 Why?
Antineoplastic Agents, Immunological
3
2019
191
0.180
 Why?
Genomic Instability
1
2022
57
0.180
 Why?
Pilonidal Sinus
1
2001
3
0.180
 Why?
Condylomata Acuminata
1
2001
7
0.180
 Why?
Proteomics
2
2020
1137
0.180
 Why?
Drug Monitoring
2
2019
396
0.180
 Why?
Hematopoiesis
1
2022
193
0.180
 Why?
Aged, 80 and over
7
2025
7948
0.170
 Why?
Nausea
2
2018
111
0.170
 Why?
Piperazines
1
2023
375
0.170
 Why?
Ki-67 Antigen
2
2019
111
0.170
 Why?
Mass Spectrometry
1
2004
734
0.170
 Why?
Retrospective Studies
10
2025
16447
0.170
 Why?
Dyspareunia
1
2020
8
0.170
 Why?
Mice, Inbred BALB C
6
2019
1261
0.160
 Why?
Cancer Care Facilities
1
2020
43
0.160
 Why?
Body Image
3
2020
99
0.160
 Why?
Ibuprofen
2
2018
82
0.160
 Why?
Pregnancy-Associated Plasma Protein-A
1
2020
14
0.160
 Why?
Biopsy
4
2018
1073
0.160
 Why?
Risk
3
2013
903
0.160
 Why?
Carcinoma, Non-Small-Cell Lung
2
2021
1125
0.160
 Why?
Tumor Microenvironment
6
2021
711
0.160
 Why?
Resistance Training
1
2022
169
0.160
 Why?
Neoplasm Grading
5
2021
311
0.160
 Why?
Mice, Inbred NOD
1
2021
599
0.160
 Why?
p21-Activated Kinases
1
2019
13
0.150
 Why?
Benzodiazepines
1
2021
162
0.150
 Why?
Bone Neoplasms
2
2016
249
0.150
 Why?
Fatigue
2
2018
342
0.150
 Why?
Parkinson Disease
2
2015
571
0.150
 Why?
Sexual Health
1
2020
67
0.150
 Why?
Cell Adhesion
1
2020
448
0.150
 Why?
Immunohistochemistry
8
2019
1724
0.150
 Why?
Receptor, trkB
1
2019
35
0.150
 Why?
Sexual Dysfunctions, Psychological
1
2019
30
0.150
 Why?
Cell Communication
1
2020
306
0.150
 Why?
Carcinoma, Ductal
2
2011
10
0.150
 Why?
Pyrazoles
3
2018
482
0.150
 Why?
Lymphangiogenesis
2
2018
26
0.150
 Why?
Response Evaluation Criteria in Solid Tumors
1
2018
19
0.150
 Why?
Germ Cells
3
2024
63
0.140
 Why?
Social Support
3
2022
629
0.140
 Why?
Nuclear Receptor Subfamily 1, Group F, Member 3
1
2018
14
0.140
 Why?
Tryptophan Oxygenase
1
2018
34
0.140
 Why?
Sexual Dysfunction, Physiological
1
2019
66
0.140
 Why?
Ipilimumab
1
2018
39
0.140
 Why?
Neoplasm Proteins
2
2020
435
0.140
 Why?
Progesterone
2
2025
258
0.140
 Why?
Parenting
1
2022
319
0.140
 Why?
Brain-Derived Neurotrophic Factor
1
2019
142
0.140
 Why?
Cisplatin
1
2020
328
0.140
 Why?
Vitamin D
1
2021
401
0.140
 Why?
Area Under Curve
1
2018
324
0.140
 Why?
Tretinoin
1
2018
121
0.130
 Why?
T-Lymphocytes, Regulatory
2
2018
393
0.130
 Why?
Immunity, Mucosal
1
2018
96
0.130
 Why?
Programmed Cell Death 1 Receptor
1
2019
258
0.130
 Why?
Tryptophan
1
2018
179
0.130
 Why?
Patient Care Management
1
2017
55
0.130
 Why?
Receptors, Antigen, T-Cell
2
2023
716
0.130
 Why?
Granulocytes
1
2017
81
0.130
 Why?
Drug Delivery Systems
2
2010
361
0.130
 Why?
Global Health
1
2020
384
0.130
 Why?
Case-Control Studies
3
2020
3577
0.130
 Why?
Socioeconomic Factors
5
2021
1311
0.130
 Why?
Carcinoma, Squamous Cell
1
2001
641
0.120
 Why?
Protein-Tyrosine Kinases
1
2019
428
0.120
 Why?
Metaplasia
1
2016
58
0.120
 Why?
Pancreatic Cyst
1
2017
48
0.120
 Why?
Cell Transformation, Neoplastic
3
2015
334
0.120
 Why?
Radiotherapy, Image-Guided
1
2016
38
0.120
 Why?
Surveys and Questionnaires
8
2024
5948
0.120
 Why?
Genetic Testing
2
2016
462
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
98
0.120
 Why?
Mammography
1
2017
157
0.120
 Why?
Dyskinesia, Drug-Induced
1
1995
14
0.120
 Why?
Cellular Microenvironment
1
2016
91
0.120
 Why?
United States
7
2024
15298
0.120
 Why?
Prostatic Neoplasms
2
2021
1050
0.120
 Why?
Levodopa
1
1995
39
0.120
 Why?
Antiparkinson Agents
1
1995
40
0.120
 Why?
Epithelium
2
2015
311
0.120
 Why?
Depression
3
2020
1490
0.120
 Why?
Cytophagocytosis
1
2015
5
0.120
 Why?
Transforming Growth Factor beta3
1
2015
10
0.120
 Why?
Lung Neoplasms
2
2021
2554
0.120
 Why?
Prophylactic Surgical Procedures
1
2015
7
0.120
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2018
350
0.120
 Why?
Adherens Junctions
1
2015
24
0.120
 Why?
Paracrine Communication
1
2015
66
0.110
 Why?
Chronic Pain
1
2019
281
0.110
 Why?
Phosphoproteins
2
2015
332
0.110
 Why?
Menarche
1
2015
53
0.110
 Why?
Rats
6
2021
5556
0.110
 Why?
Lymphocyte Activation
3
2017
1136
0.110
 Why?
Risk Reduction Behavior
1
2016
227
0.110
 Why?
Spleen
1
2017
512
0.110
 Why?
Hodgkin Disease
1
2016
158
0.110
 Why?
Lymph Node Excision
2
2021
169
0.110
 Why?
Cross-Sectional Studies
6
2022
5653
0.110
 Why?
Microfilament Proteins
1
2015
133
0.110
 Why?
Pyrimidines
1
2018
510
0.110
 Why?
Gastrointestinal Microbiome
1
2022
716
0.110
 Why?
Survival Analysis
4
2021
1322
0.110
 Why?
Aging
1
2025
1919
0.110
 Why?
Survivors
3
2023
501
0.110
 Why?
Genes, BRCA2
2
2015
30
0.110
 Why?
Mammary Neoplasms, Animal
1
2014
33
0.110
 Why?
Amenorrhea
1
2014
31
0.110
 Why?
Administration, Oral
3
2025
825
0.110
 Why?
Extracellular Matrix
2
2016
554
0.110
 Why?
Odds Ratio
4
2020
1057
0.110
 Why?
Genes, BRCA1
2
2015
41
0.110
 Why?
Pregnancy Outcome
3
2023
453
0.110
 Why?
Calcium-Binding Proteins
1
2015
213
0.110
 Why?
Carbon Cycle
1
2014
13
0.110
 Why?
Brain Edema
1
2014
63
0.110
 Why?
Multivariate Analysis
2
2019
1505
0.110
 Why?
Droughts
1
2014
30
0.100
 Why?
Monocytes
1
2017
544
0.100
 Why?
Collagen
2
2021
452
0.100
 Why?
Disability Evaluation
1
2015
304
0.100
 Why?
Spouses
1
2015
107
0.100
 Why?
Male
20
2022
70140
0.100
 Why?
Tremor
1
1994
97
0.100
 Why?
Astrocytes
1
2015
216
0.100
 Why?
Signal Transduction
4
2020
5116
0.100
 Why?
Neoplastic Cells, Circulating
2
2016
76
0.100
 Why?
Atmosphere
1
2014
84
0.100
 Why?
Nitriles
1
2014
189
0.100
 Why?
Infertility, Female
1
2014
110
0.100
 Why?
Antigens, Differentiation, Myelomonocytic
3
2019
66
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2012
983
0.100
 Why?
Triazoles
1
2014
163
0.100
 Why?
Trans-Activators
1
2015
395
0.100
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
26
0.100
 Why?
Lymphatic Vessels
3
2019
62
0.100
 Why?
Postural Balance
1
2015
238
0.090
 Why?
Genome-Wide Association Study
1
2019
1408
0.090
 Why?
Myeloid Cells
1
2013
147
0.090
 Why?
Drug Design
1
2013
169
0.090
 Why?
Cardiovascular Diseases
1
2024
2091
0.090
 Why?
Live Birth
2
2023
68
0.090
 Why?
Analgesics, Opioid
1
2021
1117
0.090
 Why?
Apoptosis
3
2019
2487
0.090
 Why?
Logistic Models
5
2016
2098
0.090
 Why?
Genes, Bacterial
1
2012
165
0.090
 Why?
Mice, Inbred C57BL
6
2019
5866
0.090
 Why?
Fibrillar Collagens
1
2011
14
0.090
 Why?
Wound Healing
1
2014
349
0.090
 Why?
Interpersonal Relations
1
2015
406
0.090
 Why?
Double-Blind Method
3
2021
1992
0.090
 Why?
Patient Participation
1
2015
427
0.090
 Why?
Transcriptome
2
2021
1007
0.090
 Why?
Real-Time Polymerase Chain Reaction
1
2012
343
0.090
 Why?
Streptococcus agalactiae
1
2012
91
0.090
 Why?
Membrane Proteins
2
2015
1144
0.090
 Why?
Antigen Presentation
2
2018
213
0.080
 Why?
Biopsy, Needle
1
2011
189
0.080
 Why?
Xenograft Model Antitumor Assays
3
2020
917
0.080
 Why?
Adenocarcinoma
2
2015
897
0.080
 Why?
Estrogen Antagonists
1
2010
45
0.080
 Why?
Sexual Behavior
1
2014
493
0.080
 Why?
Cell Fusion
2
2006
49
0.080
 Why?
Clinical Trials as Topic
3
2017
1035
0.080
 Why?
Pregnancy Trimester, Second
1
2009
80
0.080
 Why?
Radiotherapy, Adjuvant
2
2021
217
0.080
 Why?
Mucin-1
1
2009
21
0.070
 Why?
Sentinel Lymph Node Biopsy
3
2021
115
0.070
 Why?
Reference Standards
2
2012
180
0.070
 Why?
In Situ Hybridization, Fluorescence
3
2019
310
0.070
 Why?
Cell Movement
3
2019
962
0.070
 Why?
Interferon beta-1a
1
2008
13
0.070
 Why?
Glatiramer Acetate
1
2008
18
0.070
 Why?
Pregnancy Trimester, First
1
2009
136
0.070
 Why?
Macrophage Activation
1
2010
192
0.070
 Why?
Clinical Trials, Phase I as Topic
2
2020
51
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
188
0.070
 Why?
Rats, Sprague-Dawley
4
2016
2511
0.070
 Why?
Dose-Response Relationship, Drug
3
2018
2047
0.070
 Why?
Metalloproteases
1
2008
42
0.070
 Why?
Interferon-beta
1
2008
93
0.070
 Why?
Sensitivity and Specificity
3
2013
1973
0.070
 Why?
Gonadal Steroid Hormones
1
2009
140
0.070
 Why?
Extracellular Matrix Proteins
1
2009
156
0.070
 Why?
Age of Onset
2
2021
536
0.070
 Why?
Cell Cycle
2
2021
601
0.070
 Why?
Genomics
2
2023
811
0.070
 Why?
Intercellular Signaling Peptides and Proteins
1
2009
387
0.070
 Why?
Maximum Tolerated Dose
2
2018
204
0.070
 Why?
Disease Susceptibility
1
2009
351
0.070
 Why?
ErbB Receptors
3
2017
612
0.060
 Why?
Gene Knockdown Techniques
2
2020
331
0.060
 Why?
HIV Infections
1
2001
2981
0.060
 Why?
Antibodies, Monoclonal
3
2009
1456
0.060
 Why?
Sternum
1
2006
29
0.060
 Why?
Mice, Nude
3
2015
700
0.060
 Why?
Cell Survival
2
2020
1123
0.060
 Why?
Membrane Glycoproteins
2
2019
490
0.060
 Why?
Postmenopause
2
2005
369
0.060
 Why?
Cells, Cultured
3
2019
4149
0.060
 Why?
Ovariectomy
2
2019
158
0.060
 Why?
Polymerase Chain Reaction
2
2016
1050
0.060
 Why?
Axilla
2
2021
48
0.060
 Why?
Mammaplasty
2
2021
119
0.060
 Why?
Forkhead Transcription Factors
2
2018
200
0.060
 Why?
Child
6
2022
22390
0.060
 Why?
Fear
2
2021
344
0.060
 Why?
Models, Biological
2
2012
1810
0.060
 Why?
Prolactin
1
2025
92
0.060
 Why?
Mice, Knockout
2
2025
3042
0.060
 Why?
Anti-Mullerian Hormone
1
2025
58
0.060
 Why?
Thyrotropin
1
2025
116
0.060
 Why?
Infant, Newborn
2
2023
6270
0.060
 Why?
Dendritic Cells
2
2005
487
0.060
 Why?
Enzyme Inhibitors
1
2008
835
0.050
 Why?
Solubility
1
2005
239
0.050
 Why?
Analysis of Variance
3
2014
1312
0.050
 Why?
Congresses as Topic
1
2026
223
0.050
 Why?
Ovulation Induction
1
2024
56
0.050
 Why?
Neoplastic Processes
1
2023
4
0.050
 Why?
Follicle Stimulating Hormone
1
2025
247
0.050
 Why?
Weaning
2
2016
46
0.050
 Why?
Cancer Vaccines
1
2005
165
0.050
 Why?
Epithelial-Mesenchymal Transition
1
2025
213
0.050
 Why?
North America
1
2024
304
0.050
 Why?
Cryopreservation
1
2024
105
0.050
 Why?
Celecoxib
2
2014
39
0.050
 Why?
Peptide YY
1
2022
17
0.050
 Why?
Ghrelin
1
2022
36
0.050
 Why?
Peptides
1
2008
971
0.050
 Why?
Withholding Treatment
1
2023
76
0.050
 Why?
Sensation
1
2022
56
0.050
 Why?
DNA End-Joining Repair
1
2022
22
0.050
 Why?
Appetite
1
2022
71
0.050
 Why?
Mucins
1
2022
75
0.050
 Why?
Cost of Illness
1
2024
311
0.050
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2023
334
0.050
 Why?
Chromosome Aberrations
1
2022
161
0.050
 Why?
Multiple Myeloma
1
2005
280
0.050
 Why?
Heterozygote
1
2022
306
0.050
 Why?
Colorado
3
2020
4599
0.040
 Why?
Psychiatric Status Rating Scales
2
2015
552
0.040
 Why?
Chemoradiotherapy, Adjuvant
1
2021
44
0.040
 Why?
Genes, p53
1
2021
68
0.040
 Why?
Referral and Consultation
1
2007
802
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2021
113
0.040
 Why?
Placebos
1
2021
195
0.040
 Why?
Reproducibility of Results
2
2012
3345
0.040
 Why?
Hypertrophy
1
2021
133
0.040
 Why?
In Situ Hybridization
1
2001
319
0.040
 Why?
Protective Agents
1
2021
41
0.040
 Why?
Early Detection of Cancer
1
2026
432
0.040
 Why?
Neoplasm, Residual
1
2021
130
0.040
 Why?
Immunity
1
2021
138
0.040
 Why?
DNA Replication
1
2022
237
0.040
 Why?
Hormones
1
2021
138
0.040
 Why?
CD4-Positive T-Lymphocytes
2
2019
1111
0.040
 Why?
Pregnancy Rate
1
2020
68
0.040
 Why?
Hospitals, University
1
2021
176
0.040
 Why?
Arm
1
2021
109
0.040
 Why?
DNA Repair
1
2022
240
0.040
 Why?
Cross-Over Studies
1
2022
578
0.040
 Why?
Multicenter Studies as Topic
1
2021
367
0.040
 Why?
Flow Cytometry
3
2013
1182
0.040
 Why?
Consolidation Chemotherapy
1
2019
10
0.040
 Why?
Morbidity
1
2021
320
0.040
 Why?
Patient Reported Outcome Measures
1
2024
451
0.040
 Why?
Confidence Intervals
1
2020
328
0.040
 Why?
Kidney Neoplasms
1
2004
400
0.040
 Why?
Age Distribution
1
2020
396
0.040
 Why?
SEER Program
1
2021
219
0.040
 Why?
Energy Intake
1
2022
510
0.040
 Why?
DNA, Viral
1
2001
363
0.040
 Why?
Base Sequence
2
2016
2170
0.040
 Why?
Vaginal Diseases
1
2019
19
0.040
 Why?
Unemployment
1
2019
43
0.040
 Why?
Fibronectins
1
2020
135
0.040
 Why?
Terminology as Topic
1
2021
244
0.040
 Why?
Severity of Illness Index
2
2019
2904
0.040
 Why?
Leuprolide
1
2019
21
0.040
 Why?
Mammary Neoplasms, Experimental
1
2019
67
0.040
 Why?
Sulfonamides
2
2014
576
0.040
 Why?
Interleukin-10
2
2014
305
0.040
 Why?
Crosses, Genetic
1
2018
133
0.040
 Why?
Weight Gain
1
2022
536
0.040
 Why?
Hot Flashes
1
2019
87
0.040
 Why?
Maintenance Chemotherapy
1
2018
38
0.040
 Why?
Factor Analysis, Statistical
1
2019
296
0.040
 Why?
Integrins
1
2018
92
0.030
 Why?
Body Weight
1
2022
992
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2019
163
0.030
 Why?
Antimetabolites, Antineoplastic
1
2018
95
0.030
 Why?
Phenotype
2
2020
3172
0.030
 Why?
Kynurenine
1
2018
115
0.030
 Why?
Contraceptives, Oral
1
2017
38
0.030
 Why?
RNA, Small Interfering
1
2020
627
0.030
 Why?
Behavior
1
2018
92
0.030
 Why?
B7-H1 Antigen
1
2019
224
0.030
 Why?
Patient Satisfaction
1
2021
695
0.030
 Why?
Dietary Supplements
1
2021
572
0.030
 Why?
Educational Status
1
2019
463
0.030
 Why?
Weight Loss
1
2022
794
0.030
 Why?
Tumor Escape
1
2017
47
0.030
 Why?
Lymphocytes, Tumor-Infiltrating
1
2018
211
0.030
 Why?
National Cancer Institute (U.S.)
1
2016
48
0.030
 Why?
Drug Therapy, Combination
1
2019
1043
0.030
 Why?
Emulsions
1
2016
56
0.030
 Why?
Cell Count
1
2017
319
0.030
 Why?
Alleles
1
2019
878
0.030
 Why?
Risk Assessment
2
2020
3522
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2024
863
0.030
 Why?
Immune Tolerance
1
2018
373
0.030
 Why?
Radiotherapy Dosage
1
2016
280
0.030
 Why?
Population Surveillance
1
2019
481
0.030
 Why?
Immunophenotyping
1
2017
325
0.030
 Why?
Antigens, Differentiation
1
2015
78
0.030
 Why?
Radiotherapy Planning, Computer-Assisted
1
2016
142
0.030
 Why?
Body Mass Index
2
2015
2390
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1610
0.030
 Why?
Medicare
1
2021
802
0.030
 Why?
Directive Counseling
1
2015
46
0.030
 Why?
Hybrid Cells
2
2005
48
0.030
 Why?
Molecular Targeted Therapy
1
2018
420
0.030
 Why?
Biomarkers
2
2021
4180
0.030
 Why?
Medication Adherence
1
2019
510
0.030
 Why?
Reproduction
1
2016
206
0.030
 Why?
Amyloid Precursor Protein Secretases
1
2015
78
0.030
 Why?
Cognition
1
2022
1226
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
254
0.030
 Why?
Posture
1
2015
193
0.030
 Why?
Tropical Climate
1
2014
20
0.030
 Why?
Genotype
1
2019
1854
0.030
 Why?
Leukocyte Common Antigens
1
2014
88
0.030
 Why?
Terminal Care
1
2018
252
0.030
 Why?
Biota
1
2014
35
0.030
 Why?
Tumor Burden
1
2015
314
0.030
 Why?
Dinoprostone
1
2014
179
0.030
 Why?
Fresh Water
1
2014
57
0.030
 Why?
Clinical Decision-Making
1
2017
341
0.030
 Why?
STAT5 Transcription Factor
1
2013
56
0.030
 Why?
Trees
1
2014
68
0.030
 Why?
Blood Cell Count
1
2013
52
0.030
 Why?
Brazil
1
2014
168
0.030
 Why?
Carbon Monoxide
1
2014
83
0.030
 Why?
Rain
1
2014
45
0.030
 Why?
Dermoscopy
1
2013
11
0.030
 Why?
Biomass
1
2014
113
0.030
 Why?
Massachusetts
1
2014
176
0.030
 Why?
Immunoblotting
1
2014
308
0.030
 Why?
Wnt Signaling Pathway
1
2015
202
0.020
 Why?
Necrosis
1
2014
245
0.020
 Why?
Family Health
1
1994
194
0.020
 Why?
Child, Preschool
2
2021
11511
0.020
 Why?
Oncogenes
1
2013
119
0.020
 Why?
Photosynthesis
1
2014
99
0.020
 Why?
Lipopolysaccharide Receptors
1
2013
88
0.020
 Why?
beta Catenin
1
2015
256
0.020
 Why?
Karyotyping
1
2012
104
0.020
 Why?
Fires
1
2014
88
0.020
 Why?
Accidental Falls
1
2015
215
0.020
 Why?
Endothelial Cells
1
2018
816
0.020
 Why?
Immune System
1
2014
183
0.020
 Why?
Adiposity
1
2017
520
0.020
 Why?
Opioid-Related Disorders
1
2021
568
0.020
 Why?
Gonadotropin-Releasing Hormone
1
2014
213
0.020
 Why?
Observer Variation
1
2013
356
0.020
 Why?
Menopause
1
2015
317
0.020
 Why?
Carbon Dioxide
1
2014
241
0.020
 Why?
Carcinogenesis
1
2013
218
0.020
 Why?
Cell Division
1
2013
792
0.020
 Why?
Comorbidity
1
2017
1671
0.020
 Why?
Calibration
1
2012
151
0.020
 Why?
Recurrence
1
2015
1108
0.020
 Why?
Polymorphism, Single Nucleotide
1
2019
2122
0.020
 Why?
Interferon-gamma
2
2005
784
0.020
 Why?
Seasons
1
2014
547
0.020
 Why?
RNA, Bacterial
1
2012
189
0.020
 Why?
Tomography, X-Ray Computed
2
2015
2765
0.020
 Why?
Cell Differentiation
1
2018
1983
0.020
 Why?
Genome, Human
1
2013
420
0.020
 Why?
Mice, SCID
1
2011
367
0.020
 Why?
Cell Line
1
2016
2863
0.020
 Why?
Photochemotherapy
1
2010
39
0.020
 Why?
Palliative Care
1
2018
820
0.020
 Why?
Self Report
1
2015
859
0.020
 Why?
Universities
1
2013
450
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2012
321
0.020
 Why?
Feasibility Studies
1
2014
1037
0.020
 Why?
Hypertension
1
2018
1250
0.020
 Why?
Microscopy, Confocal
1
2010
324
0.020
 Why?
Survival Rate
1
2014
1979
0.020
 Why?
Matrix Metalloproteinases
1
2010
95
0.020
 Why?
Keratin-19
1
2009
3
0.020
 Why?
Immunomagnetic Separation
1
2009
4
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
20
0.020
 Why?
Dose-Response Relationship, Immunologic
1
2009
77
0.020
 Why?
Physician-Patient Relations
1
2014
579
0.020
 Why?
Diagnosis, Differential
1
2013
1491
0.020
 Why?
Vinblastine
1
2009
71
0.020
 Why?
Blotting, Western
1
2011
1220
0.020
 Why?
Species Specificity
1
2010
573
0.020
 Why?
Flavonoids
1
2009
81
0.020
 Why?
ADAM12 Protein
1
2008
4
0.020
 Why?
Perilipin-1
1
2008
17
0.020
 Why?
Estrogen Receptor Modulators
1
2008
17
0.020
 Why?
S100 Proteins
1
2008
36
0.020
 Why?
Sex Factors
1
1994
2055
0.020
 Why?
ADAM Proteins
1
2008
59
0.020
 Why?
Androstadienes
1
2008
74
0.020
 Why?
Perimenopause
1
2008
64
0.020
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
134
0.020
 Why?
DNA Primers
1
2009
507
0.020
 Why?
Matrix Metalloproteinase 9
1
2008
133
0.020
 Why?
Radiotherapy
1
2008
204
0.020
 Why?
Prevalence
1
2014
2795
0.020
 Why?
Piperidines
1
2009
217
0.020
 Why?
Gene Expression
1
2012
1490
0.020
 Why?
Chi-Square Distribution
1
2008
526
0.020
 Why?
Precancerous Conditions
1
2008
163
0.020
 Why?
Cluster Analysis
1
2008
518
0.020
 Why?
Protein Structure, Tertiary
1
2009
858
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2008
757
0.010
 Why?
Pleural Effusion
1
2006
60
0.010
 Why?
Lymphocyte Culture Test, Mixed
1
2005
51
0.010
 Why?
Cytotoxicity Tests, Immunologic
1
2005
37
0.010
 Why?
Receptors, CCR7
1
2005
31
0.010
 Why?
Receptors, Chemokine
1
2005
48
0.010
 Why?
Antigens, CD34
1
2005
88
0.010
 Why?
Positron-Emission Tomography
1
2006
309
0.010
 Why?
Interleukin-12
1
2005
122
0.010
 Why?
Hemocyanins
1
2004
61
0.010
 Why?
Stress, Psychological
1
2012
1124
0.010
 Why?
Patient Care Planning
1
2005
156
0.010
 Why?
Carrier Proteins
1
2008
738
0.010
 Why?
Coculture Techniques
1
2004
244
0.010
 Why?
Cell Separation
1
2004
309
0.010
 Why?
Cell Nucleus
1
2006
607
0.010
 Why?
Tumor Cells, Cultured
1
2004
959
0.010
 Why?
Brain
1
2014
2857
0.010
 Why?
Paclitaxel
1
2003
236
0.010
 Why?
Pilot Projects
1
2003
1820
0.010
 Why?
Vaccination
1
2004
1468
0.010
 Why?
Borges's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (585) concept(s)
_
Co-Authors Expand Description
See all (69) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)